Glenmark Pharmaceuticals Schedules Physical Institutional Investor Meetings in Asia and Europe
Glenmark Pharmaceuticals Ltd 路 Intimation 路 10 Nov 2026, 3:00 am
Glenmark Pharmaceuticals Schedules Physical Institutional Investor Meetings in Asia and Europe Glenmark Pharmaceuticals announced its upcoming physical analyst and institutional investor meetings via a regulatory filing. The company is scheduled to host both group and one-on-one meetings in Taiwan and Singapore from 16th Nov'26 to 18th Nov'26. Additionally, a physical group investor meeting is scheduled to take place in Switzerland on 23rd Nov'26. The company confirmed that no unpublished price-sensitive information will be shared during these interactions.
Original exchange filing (PDF)
More announcements from Glenmark Pharmaceuticals Ltd
- Ichnos Glenmark Innovation (IGI) announces IND submission to US FDA for ISB 2301 路 18 Nov 2026
- Glenmark Pharmaceuticals Inc., USA Launches Authorised Generic of INLYTA (axitinib) Tablets, 1 mg and 5mg 路 16 Nov 2026
- Schedule of Schedule of Analyst/ Institutional Investor Meetings 路 10 Nov 2026
- Intimation of Schedule of Analyst/ Institutional Investor Meetings 路 10 Nov 2026
- Intimation of Schedule of Analyst / Institutional Investor Meetings 路 10 Nov 2026
- Transcript of the Earnings Call 路 09 Nov 2026
- Audio recording of Q2 FY 2026-27 Earnings Call held on November 06, 2026 路 06 Nov 2026
- Investor Presentation for the quarter and half year ended September 30, 2026 路 05 Nov 2026
